ICB Pharma Tomasz Swietoslawski,Pawel Swietoslawski sp. j. is a company based in Poland, with its head office in Jaworzno. The company operates in the Other Basic Organic Chemical Manufacturing sector. The company was established on February 10, 2003. The total number of employees is currently 135 (2020). From the latest financial highlights, ICB Pharma Tomasz Swietoslawski,Pawel Swietoslawski sp. j. reported a net sales revenue drop of 1.49% in 2023. Its’ total assets recorded a growth of 10.03%. In, 2023, the company’s net profit margin decreased by 3.92%.
Headquarters
Ul. Mozdzierzowcow 6A
Jaworzno; Slaskie;
Postal Code: 43-602
Contact Details: Purchase the ICB Pharma Tomasz Swietoslawski,Pawel Swietoslawski sp. j. report to view the information.
Website: http://www.icbpharma.pl
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service